Back to Search
Start Over
Identification and characterization of the direct interaction between methotrexate (MTX) and high-mobility group box 1 (HMGB1) protein
- Source :
- PLoS ONE, Vol 8, Iss 5, p e63073 (2013), PLoS ONE
- Publication Year :
- 2013
- Publisher :
- Public Library of Science (PLoS), 2013.
-
Abstract
- Background Methotrexate (MTX) is an agent used in chemotherapy of tumors and autoimmune disease including rheumatoid arthritis (RA). In addition, MTX has some anti-inflammatory activity. Although dihydrofolate reductase (DHFR) is a well-known target for the anti-tumor effect of MTX, the mode of action for the anti-inflammatory activity of MTX is not fully understood. Methodology/Result Here, we performed a screening of MTX-binding proteins using T7 phage display with a synthetic biotinylated MTX derivative. We then characterized the interactions using surface plasmon resonance (SPR) analysis and electrophoretic mobility shift assay (EMSA). Using a T7 phage display screen, we identified T7 phages that displayed part of high-mobility group box 1 (HMGB1) protein (K86-V175). Binding affinities as well as likely binding sites were characterized using genetically engineered truncated versions of HMGB1 protein (Al G1-K87, Bj: F88-K181), indicating that MTX binds to HMGB1 via two independent sites with a dissociation constants (KD) of 0.50±0.03 µM for Al and 0.24±0.01 µM for Bj. Although MTX did not inhibit the binding of HMGB1 to DNA via these domains, HMGB1/RAGE association was impeded in the presence of MTX. These data suggested that binding of MTX to part of the RAGE-binding region (K149-V175) in HMGB1 might be significant for the anti-inflammatory effect of MTX. Indeed, in murine macrophage-like cells (RAW 264.7), TNF-α release and mitogenic activity elicited by specific RAGE stimulation with a truncated monomeric HMGB1 were inhibited in the presence of MTX. Conclusions/Significance These data demonstrate that HMGB1 is a direct binding protein of MTX. Moreover, binding of MTX to RAGE-binding region in HMGB1 inhibited the HMGB1/RAGE interaction at the molecular and cellular levels. These data might explain the molecular basis underlying the mechanism of action for the anti-inflammatory effect of MTX.
- Subjects :
- Phage display
lcsh:Medicine
Electrophoretic Mobility Shift Assay
Biochemistry
RAGE (receptor)
Analytical Chemistry
Mice
Engineering
Bacteriophage T7
Dihydrofolate reductase
heterocyclic compounds
Biomacromolecule-Ligand Interactions
HMGB1 Protein
skin and connective tissue diseases
lcsh:Science
Multidisciplinary
biology
Physics
Anti-Inflammatory Agents, Non-Steroidal
Chemistry
Biotinylation
Medicine
medicine.symptom
Research Article
Biotechnology
Protein Binding
musculoskeletal diseases
Drugs and Devices
Antimetabolites, Antineoplastic
Drug Research and Development
Molecular Sequence Data
Biophysics
Bioengineering
chemical and pharmacologic phenomena
HMGB1
Cell Line
Peptide Library
medicine
Animals
Humans
Electrophoretic mobility shift assay
Amino Acid Sequence
Binding site
Biology
Binding Sites
Tumor Necrosis Factor-alpha
Macrophages
lcsh:R
Molecular biology
Kinetics
Methotrexate
Mechanism of action
biology.protein
lcsh:Q
Medicinal Chemistry
Peptides
Subjects
Details
- Language :
- English
- ISSN :
- 19326203
- Volume :
- 8
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- PLoS ONE
- Accession number :
- edsair.doi.dedup.....fae9389ebfb4cbef8a891e1e2194cd52